imiquimod has been researched along with Respiratory Syncytial Virus Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benedetti, M; Bueno, CA; Gentilini, MV; Marini, V; Nabaes Jodar, MS; Nebreda, AD; Salinas, FM; Shayo, C; Vázquez, L; Viegas, M | 1 |
| Lippolis, JD; McGill, JL; Nonnecke, BJ; Reinhardt, TA; Sacco, RE | 1 |
2 other study(ies) available for imiquimod and Respiratory Syncytial Virus Infections
| Article | Year |
|---|---|
Imiquimod suppresses respiratory syncytial virus (RSV) replication via PKA pathway and reduces RSV induced-inflammation and viral load in mice lungs.
Topics: A549 Cells; Animals; Antiviral Agents; Cell Line, Tumor; Cyclic AMP-Dependent Protein Kinases; Cytokines; Disease Models, Animal; Epithelial Cells; Female; Humans; Imiquimod; Inflammation; Lung; Mice; Mice, Inbred BALB C; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Human; Signal Transduction; Viral Load; Virus Replication | 2020 |
Differential chemokine and cytokine production by neonatal bovine γδ T-cell subsets in response to viral toll-like receptor agonists and in vivo respiratory syncytial virus infection.
Topics: Aminoquinolines; Animals; Animals, Newborn; Cattle; Cells, Cultured; Chemokines; Cytokines; Enzyme-Linked Immunosorbent Assay; Flow Cytometry; Gene Expression Profiling; Host-Pathogen Interactions; Imiquimod; Membrane Glycoproteins; Poly I-C; Receptors, Antigen, T-Cell, gamma-delta; Respiratory Syncytial Virus Infections; Respiratory Syncytial Virus, Bovine; Reverse Transcriptase Polymerase Chain Reaction; T-Lymphocyte Subsets; Time Factors; Toll-Like Receptor 3; Toll-Like Receptor 7; Toll-Like Receptors | 2013 |